Product Information

MONTELUKAST SOD 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0431 per EA under NDC 16571010010. Its NADAC has been published 154 times since Dec 13, 2023.

FDA first approved this application on Apr 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MONTELUKAST SOD 10 MG TABLET

MONTELUKAST SODIUM
$0.0431per EA

Strength

10 mg/1

NDC

16571010010

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

MONTELUKAST SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA209012

FDA Approved

4/24/2017

TE Code

AB

On Market Since

6/1/2023

Pharmacological Classes

Leukotriene Receptor Antagonist
Leukotriene Receptor Antagonists

Price Statistics

The NADAC for MONTELUKAST SOD 10 MG TABLET has been published 154 times since Dec 13, 2023, and over the history we have for it it has declined 33.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0431 per EA
All-time high$0.0679 (Jan 10, 2024)
All-time low$0.0403 (Jul 22, 2026)
52-week high$0.0486
52-week low$0.0403
Median price$0.0515
Average price$0.0509
Largest weekly change-30.8% (Nov 20, 2024)
Weeks tracked154
Tracking sinceDec 13, 2023

Price History

1W

-0.3%

1M

+2.8%

3M

+3.7%

6M

+1.4%

1Y

-11.4%

3Y

N/A

5Y

N/A

All

-33.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MONTELUKAST SOD 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MONTELUKAST SOD 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0431 per EA (NDC 16571010010), effective Nov 18, 2026.

How has the price of MONTELUKAST SOD 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for MONTELUKAST SOD 10 MG TABLET has declined 33.5%. It has been tracked across 154 weekly CMS publications since Dec 13, 2023.

What are the highest and lowest recorded NADAC prices for MONTELUKAST SOD 10 MG TABLET?

Since Dec 13, 2023, the NADAC for MONTELUKAST SOD 10 MG TABLET has ranged from a low of $0.0403 (Jul 22, 2026) to a high of $0.0679 (Jan 10, 2024), with a median of $0.0515 per EA.

Are there cheaper alternatives to MONTELUKAST SOD 10 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MONTELUKAST SOD 10 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MONTELUKAST SOD 10 MG TABLET?

MONTELUKAST SOD 10 MG TABLET (NDC 16571010010) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.